Stryker Company Leadership

SYK Stock  USD 357.44  1.27  0.35%   
About 92 percent of Stryker's insiders are activelly selling. The analysis of insiders' sentiment of trading Stryker stock suggests that many insiders are panicking at this time. Stryker employs about 52 K people. The company is managed by 43 executives with a total tenure of roughly 382 years, averaging almost 8.0 years of service per executive, having 1209.3 employees per reported executive.
Kevin Lobo  Chairman
Chairman of the Board, President, Chief Executive Officer
William Parfet  Chairman
Non-Executive Independent Chairman of the Board

Stryker's Insider Buying Vs Selling

8

 
Selling
 
Buying

Latest Trades

2024-03-07William E Berry JrDisposed 7690 @ 358.48View
2024-02-05Ronda E StrykerDisposed 201146 @ 342.9View
2024-02-02Allan C GolstonDisposed 3273 @ 341View
2023-11-28William E Berry JrDisposed 573 @ 292.28View
2023-11-17Kevin LoboDisposed 56483 @ 287.91View
2023-11-16Srikant M DatarDisposed 500 @ 291.92View
2023-11-14Srikant M DatarDisposed 750 @ 287.57View
2023-10-24Greg StantonDisposed @ 265.06
2023-09-26Greg StantonAcquired @ 273.54
2023-09-06Viju MenonDisposed 5000 @ 289View
2023-06-01Srikant M DatarDisposed 500 @ 278.5View
2023-05-18Srikant M DatarDisposed 1000 @ 286View
Monitoring Stryker's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.

Acquired vs Disposed

Filed vs Not Filed

Insider sentiment refers to the collective sentiment or feeling of Stryker's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Stryker. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Stryker's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

Stryker's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Stryker's future performance. Based on our forecasts, it is anticipated that Stryker will maintain a workforce of about 52000 employees by April 2024.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Stryker's latest congressional trading

Congressional trading in companies like Stryker, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Stryker by those in governmental positions are based on the same information available to the general public.
2023-09-26Representative Greg StantonAcquired Under $15KVerify
2023-03-17Representative Michael C. BurgessDisposed $15K to $50KVerify
2023-02-24Representative Thomas H. KeanDisposed $15K to $50KVerify
2022-11-30Senator Daniel S SullivanAcquired Under $15KVerify
2022-11-30Senator Dan SullivanAcquired Under $15KVerify
2022-01-06Representative Rick LarsenAcquired Under $15KVerify
2021-04-09Representative Sara JacobsDisposed $15K to $50KVerify
2020-09-16Representative Gilbert CisnerosAcquired Under $15KVerify
2020-04-14Senator David A Perdue , JrAcquired Under $15KVerify
2020-04-14Senator David PerdueAcquired Under $15KVerify
2019-12-31Representative Cynthia AxneAcquired Under $15KVerify
2019-02-28Senator Jack ReedAcquired Under $15KVerify
2017-08-24Senator Sheldon WhitehouseAcquired Under $15KVerify
2016-09-08Senator Susan M. CollinsAcquired $50K to $100KVerify

Stryker Management Team Effectiveness

The company has Return on Asset of 0.0687 % which means that on every $100 spent on assets, it made $0.0687 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1798 %, implying that it generated $0.1798 on every 100 dollars invested. Stryker's management efficiency ratios could be used to measure how well Stryker manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is expected to rise to 0.21 this year. Return On Assets is expected to rise to 0.11 this year. At this time, Stryker's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 41.9 B this year, although the value of Non Current Liabilities Other will most likely fall to about 1.8 B.
Common Stock Shares Outstanding is expected to rise to about 426.3 M this year. Net Income Applicable To Common Shares is expected to rise to about 2.8 B this year

Stryker Workforce Comparison

Stryker is rated third in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 187,593. Stryker totals roughly 52,000 in number of employees claiming about 28% of equities under Health Care industry.

Stryker Profit Margins

The company has Net Profit Margin of 0.15 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.24 %, which entails that for every 100 dollars of revenue, it generated $0.24 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.50.637
Significantly Down
Pretty Stable
Net Profit Margin0.0960.1544
Way Down
Very volatile
Operating Profit Margin0.140.1897
Way Down
Pretty Stable
Pretax Profit Margin0.130.1792
Way Down
Slightly volatile
Return On Assets0.110.0793
Significantly Up
Pretty Stable
Return On Equity0.190.1702
Moderately Up
Pretty Stable

Stryker Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Stryker insiders, such as employees or executives, is commonly permitted as long as it does not rely on Stryker's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Stryker insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.871
27
31
 354,106 
 1,421,346 
2023-12-01
0.2692
7
26
 198,416 
 385,449 
2023-09-01
0.2
1
5
 2,000 
 8,739 
2023-06-01
1.0
14
14
 10,550 
 225,022 
2023-03-01
0.5455
36
66
 345,350 
 1,250,084 
2022-12-01
0.3158
6
19
 199,369 
 395,988 
2022-09-01
0.25
1
4
 2,343 
 2,244 
2022-06-01
0.8421
16
19
 28,902 
 765,950 
2022-03-01
1.25
25
20
 417,297 
 97,723 
2021-12-01
0.2045
9
44
 19,897 
 353,176 
2021-09-01
0.2857
2
7
 5,659 
 725,526 
2021-06-01
1.2105
23
19
 145,604 
 255,379 
2021-03-01
1.2
18
15
 339,679 
 139,015 
2020-12-01
0.3077
4
13
 128,520 
 228,124 
2020-09-01
0.5
4
8
 32,567 
 200,987 
2020-06-01
0.4857
17
35
 41,562 
 89,036 
2020-03-01
0.9286
26
28
 458,663 
 779,602 
2019-12-01
0.625
5
8
 13,706 
 44,984 
2019-09-01
0.4828
14
29
 71,723 
 349,233 
2019-06-01
1.0
20
20
 36,305 
 63,969 
2019-03-01
0.8
36
45
 607,254 
 324,744 
2018-12-01
0.3684
7
19
 47,042 
 84,753 
2018-09-01
1.2
6
5
 49,487 
 76,332 
2018-06-01
0.7647
13
17
 12,908 
 75,419 
2018-03-01
0.8103
47
58
 699,630 
 348,088 
2017-12-01
0.2727
3
11
 46,551 
 114,139 
2017-09-01
0.625
5
8
 8,172 
 31,826 
2017-06-01
0.5
18
36
 393,330 
 720,492 
2017-03-01
1.16
58
50
 685,925 
 157,362 
2016-12-01
0.0704
5
71
 32,684 
 451,961 
2016-09-01
0.0429
3
70
 6,720 
 417,482 
2016-06-01
0.098
10
102
 133,995 
 770,179 
2016-03-01
0.4472
55
123
 748,537 
 741,629 
2015-12-01
0.08
6
75
 101,481 
 556,137 
2015-09-01
0.0145
1
69
 5,000 
 410,974 
2015-06-01
0.2273
5
22
 31,043 
 1,142,550 
2015-03-01
1.26
63
50
 634,149 
 600,207 
2014-12-01
0.0682
3
44
 32,151 
 327,200 
2014-09-01
0.0385
1
26
 12,000 
 185,000 
2014-06-01
0.0313
1
32
 8,618 
 203,142 
2014-03-01
0.8182
45
55
 496,980 
 275,763 
2013-12-01
0.0323
2
62
 48,950 
 491,978 
2013-09-01
0.0513
2
39
 24,000 
 281,853 
2013-06-01
0.1143
4
35
 143,956 
 326,134 
2013-03-01
1.0286
36
35
 486,613 
 160,018 
2012-12-01
0.0714
2
28
 13,801 
 244,000 
2012-06-01
0.0313
1
32
 10,000 
 289,000 
2012-03-01
1.1379
33
29
 303,981 
 215,132 
2011-06-01
0.1585
13
82
 443,418 
 1,575,037 
2011-03-01
0.6222
28
45
 518,512 
 452,560 
2010-12-01
0.1667
1
6
 2,000 
 340,000 
2010-03-01
0.8333
25
30
 739,758 
 898,375 
2009-09-01
0.16
4
25
 17,330 
 2,010,500 
2009-06-01
0.5
4
8
 21,750 
 280,000 
2009-03-01
7.5
15
2
 606,875 
 40,000 
2008-09-01
0.2381
5
21
 107,000 
 609,151 
2008-03-01
0.2564
10
39
 302,850 
 1,254,326 
2007-12-01
0.1538
6
39
 196,000 
 1,235,115 
2007-09-01
0.0256
1
39
 1,000.00 
 750,000 
2005-12-01
1.0
1
1
 5,000 
 525.00 
2005-06-01
0.7273
8
11
 367,000 
 940,000 
2004-09-01
0.5
1
2
 2,500 
 265,555 
2004-03-01
0.9
9
10
 133,600 
 232,893 
2003-12-01
0.65
13
20
 466,000 
 727,034 
2003-09-01
0.25
2
8
 93,034 
 425,034 

Stryker Notable Stakeholders

A Stryker stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Stryker often face trade-offs trying to please all of them. Stryker's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Stryker's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kevin LoboChairman of the Board, President, Chief Executive OfficerProfile
William ParfetNon-Executive Independent Chairman of the BoardProfile
FinkVice President Global Human ResourcesProfile
William BerryPrincipal Accounting Officer, Vice President, Corporate ControllerProfile
Katherine OwenVice President - Strategy and Investor RelationsProfile
Graham McleanPresident Asia-PacificProfile
David FloydGroup President of OrthopaedicsProfile
Yin BeckerVice President - Communications, Public Affairs and Corporate MarketingProfile
Timothy ScannellGroup President of Medsurg and NeurotechnologyProfile
Robert FletcherVice President Chief Legal OfficerProfile
Glenn BoehnleinChief Financial Officer, Vice PresidentProfile
Viju MenonGroup President - Global Quality and Business OperationsProfile
Lonny CarpenterGroup President - Global Quality and OperationsProfile
Bijoy SagarChief Digital Technology Officer, Vice PresidentProfile
Bronwen TaylorVice President - Compliance and Risk ManagementProfile
Steven BenscoterVice President - Human ResourcesProfile
Kathryn FinkChief Human Resource Officer, Vice PresidentProfile
Scott BruderVice President Chief Medical and Scientific OfficerProfile
William JellisonCFO and VPProfile
Andrew SilvernailIndependent DirectorProfile
Sherilyn McCoyIndependent DirectorProfile
Ronda StrykerIndependent DirectorProfile
Allan GolstonLead Independent DirectorProfile
Louise FrancesconiIndependent DirectorProfile
Giovanni CaforioIndependent DirectorProfile
Roch DoliveuxIndependent DirectorProfile
Rajeev SuriIndependent DirectorProfile
Mary BrainerdIndependent DirectorProfile
Srikant DatarIndependent DirectorProfile
Howard CoxIndependent DirectorProfile
Dean BergyVP and Corporate SecretaryProfile
Lisa TatumIndependent DirectorProfile
Robert CohenCTO ReplacementProfile
Preston WellsVice President - Investor RelationsProfile
Curtis HallChief Legal OfficerProfile
Ramesh SubrahmanianAdvisorProfile
Spencer StilesGroup President Orthopaedics and SpineProfile
Andrew PierceGroup NeurotechnologyProfile
Jason BeachVice RelationsProfile
M FinkChief Human Resource Officer, Vice PresidentProfile
Alan DouvilleChief VPProfile
J PierceGroup President MedSurg and NeurotechnologyProfile
Michael HutchinsonGeneral CounselProfile

About Stryker Management Performance

The success or failure of an entity such as Stryker often depends on how effective the management is. Stryker management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Stryker management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Stryker management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for 2024
Return On Capital Employed 0.12  0.21 
Return On Assets 0.08  0.11 
Return On Equity 0.17  0.19 
The data published in Stryker's official financial statements usually reflect Stryker's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Stryker. For example, before you start analyzing numbers published by Stryker accountants, it's critical to develop an understanding of what Stryker's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Stryker's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Stryker's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Stryker's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Stryker. Please utilize our Beneish M Score to check the likelihood of Stryker's management manipulating its earnings.

Stryker Workforce Analysis

Traditionally, organizations such as Stryker use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Stryker within its industry.

Stryker Manpower Efficiency

Return on Stryker Manpower

Revenue Per Employee394.2K
Revenue Per Executive476.7M
Net Income Per Employee60.9K
Net Income Per Executive73.6M
Working Capital Per Employee88.4K
Working Capital Per Executive106.9M
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Stryker Stock analysis

When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.027
Dividend Share
3.05
Earnings Share
8.23
Revenue Per Share
53.999
Quarterly Revenue Growth
0.118
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.